“…One such mechanism is so-called “block carryover”, as reported in Waataja et al ( 2011 ); Liu et al ( 2013 ); Bhadra et al ( 2017 ); Yang et al ( 2017 ), and Pelot and Grill ( 2020 ), describing a process by which nerve excitability remains suppressed after application of HFAC block. This effect is not captured by computational simulations of nerve cells being stimulated by high-frequency signals (Ackermann et al, 2011 ; Liu et al, 2013 ; Pelot et al, 2017 ; Perra et al, 2018 ), requiring characterization before HFAC stimulation can be used in a clinical context. Furthermore, previous experimental work with HFAC has not always observed carryover block (Kilgore and Bhadra, 2004 ), indicating that the conditions in which carryover block occurs may be unclear and require clarification.…”